Ebaston Thankarajan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ebaston Thankarajan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Leonid D. Patsenker
Department of Chemical Sciences, Ariel University, Ariel 40700, Israel
4 shared publications - Gary Gellerman
Department of Chemical Sciences, Ariel University, Ariel 4070000, Israel
3 shared publications Helena Tuchinsky
Department of Molecular Biology, Ariel University, Ariel, Israel
3 shared publicationsAlisa Zaporozhets
Department of Chemical Sciences, Ariel University, Ariel 40700, Israel
2 shared publicationsAlex Rozovsky
Department of Chemical Sciences, Ariel University, Ariel, 40700, Israel
1 shared publication- Alex Rozovsky
Department of Chemical Sciences, Ariel University, Ariel 40700, Israel
1 shared publication
Latest Publications
- 11 June 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (8) , 1641-1651
Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells
Ratiometric measurements utilizing two independent fluorescence signals from a dual-dye molecular system help to improve the detection sensitivity and quantification of many analytical, bioanalytical, and pharmaceutical assays, including drug delivery monitoring. Nevertheless, these dual-dye conjugates have never been utilized for ratiometric monitoring of antibody (Ab)-guided targeted drug delivery (TDD). Here, we report for the first time on the new, dual-dye TDD system, Cy5s-Ab-Flu-Aza, comprising the switchable fluorescein-based dye (Flu) linked to the anticancer drug azatoxin (Aza), reference pentamethine cyanine dye (Cy5s), and Her2-specific humanized monoclonal Trastuzumab (Herceptin) antibody. The ability of ratiometric fluorescence monitoring of drug release was demonstrated with this model system in vitro in the example of the human breast cancer SKBR3 cell line overexpressing Her2 receptors. The proposed approach for designing ratiometric, antibody-guided TDD systems, where a “drug–switchable dye” conjugate and a reference dye are independently linked to an antibody, can be expanded to other drugs, dyes, and antibodies. Replacement of the green-emitting dye Flu, which was found not detectable in vivo, with a longer-wavelength (red or near-IR) switchable fluorophore should enable quantification of drug release in the body.
- 11 June 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (8) , 1641-1651
Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells
Ratiometric measurements utilizing two independent fluorescence signals from a dual-dye molecular system help to improve the detection sensitivity and quantification of many analytical, bioanalytical, and pharmaceutical assays, including drug delivery monitoring. Nevertheless, these dual-dye conjugates have never been utilized for ratiometric monitoring of antibody (Ab)-guided targeted drug delivery (TDD). Here, we report for the first time on the new, dual-dye TDD system, Cy5s-Ab-Flu-Aza, comprising the switchable fluorescein-based dye (Flu) linked to the anticancer drug azatoxin (Aza), reference pentamethine cyanine dye (Cy5s), and Her2-specific humanized monoclonal Trastuzumab (Herceptin) antibody. The ability of ratiometric fluorescence monitoring of drug release was demonstrated with this model system in vitro in the example of the human breast cancer SKBR3 cell line overexpressing Her2 receptors. The proposed approach for designing ratiometric, antibody-guided TDD systems, where a “drug–switchable dye” conjugate and a reference dye are independently linked to an antibody, can be expanded to other drugs, dyes, and antibodies. Replacement of the green-emitting dye Flu, which was found not detectable in vivo, with a longer-wavelength (red or near-IR) switchable fluorophore should enable quantification of drug release in the body.
- Open Access
- 14 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (56) , 32656-32664
Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
Conjugation of an anticancer drug with a cancer-specific carrier and a fluorescent dye to form a theranostic system enables real time monitoring of targeted drug delivery (TDD). However, the fluorescence signal from the dye is affected by the light absorption and scattering in the body, photobleaching, and instrumental parameters. Ratiometric measurements utilizing two fluorescence signals of different wavelengths are known to improve sensitivity, reliability and quantitation of fluorescence measurements in biological media. Herein, a novel theranostic system comprising the anticancer drug chlorambucil (CLB), cancer-specific peptide octreotide amide (OctA), and a long-wavelength dual fluorescent cyanine dye IRD enabling ratiometric monitoring of drug delivery was developed and evaluated on the cancer cell line PANC-1.
- 14 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (56) , 32656-32664
Open AccessTheranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
Conjugation of an anticancer drug with a cancer-specific carrier and a fluorescent dye to form a theranostic system enables real time monitoring of targeted drug delivery (TDD). However, the fluorescence signal from the dye is affected by the light absorption and scattering in the body, photobleaching, and instrumental parameters. Ratiometric measurements utilizing two fluorescence signals of different wavelengths are known to improve sensitivity, reliability and quantitation of fluorescence measurements in biological media. Herein, a novel theranostic system comprising the anticancer drug chlorambucil (CLB), cancer-specific peptide octreotide amide (OctA), and a long-wavelength dual fluorescent cyanine dye IRD enabling ratiometric monitoring of drug delivery was developed and evaluated on the cancer cell line PANC-1.
- 12 August 2019
- Published by Wiley in ChemMedChem
- Vol. 14 (19) , 1727-1734
Peptide‐Driven Targeted Drug‐Delivery System Comprising Turn‐On Near‐Infrared Fluorescent Xanthene–Cyanine Reporter for Real‐Time Monitoring of Drug Release
Targeted drug delivery (TDD) is an efficient strategy for cancer treatment. However, the real‐time monitoring of drug delivery is still challenging because of a pronounced lack of TDD systems capable of providing a near‐infrared (NIR) fluorescence signal for the detection of drug‐release events. Herein, a new TDD system, comprising a turn‐on NIR fluorescent reporter attached to an anticancer drug and targeting peptide, is reported. This system provides both TDD and NIR fluorescence monitoring of drug‐release events in target tissue. In this TDD system, a new carboxy‐derivatized xanthene–cyanine (XCy) dye is attached to an anticancer drug, chlorambucil (CLB), through a hydrolytically cleavable ester linker and coupled to a targeting peptide, octreotide amide (OCTA), which is specific to somatostatin receptors SSTR‐2 and STTR‐5 overexpressed on many tumor cells. This OCTA‐G‐XCy‐CLB (G: γ‐aminobutyric acid) conjugate exhibits no detectable fluorescence, whereas, upon the hydrolytic cleavage of the ester linker, a bright NIR fluorescence appears at λ≈710 nm; this signals release of the drug. Real‐time TDD monitoring is demonstrated for the example of the human pancreatic cancer cell line overexpressing SSTR‐2 and STTR‐5, in comparison with the noncancerous Chinese hamster ovary cell line, which contains a reduced number of these receptors.
- 12 August 2019
- Published by Wiley in ChemMedChem
- Vol. 14 (19) , 1727-1734
Peptide‐Driven Targeted Drug‐Delivery System Comprising Turn‐On Near‐Infrared Fluorescent Xanthene–Cyanine Reporter for Real‐Time Monitoring of Drug Release
Targeted drug delivery (TDD) is an efficient strategy for cancer treatment. However, the real‐time monitoring of drug delivery is still challenging because of a pronounced lack of TDD systems capable of providing a near‐infrared (NIR) fluorescence signal for the detection of drug‐release events. Herein, a new TDD system, comprising a turn‐on NIR fluorescent reporter attached to an anticancer drug and targeting peptide, is reported. This system provides both TDD and NIR fluorescence monitoring of drug‐release events in target tissue. In this TDD system, a new carboxy‐derivatized xanthene–cyanine (XCy) dye is attached to an anticancer drug, chlorambucil (CLB), through a hydrolytically cleavable ester linker and coupled to a targeting peptide, octreotide amide (OCTA), which is specific to somatostatin receptors SSTR‐2 and STTR‐5 overexpressed on many tumor cells. This OCTA‐G‐XCy‐CLB (G: γ‐aminobutyric acid) conjugate exhibits no detectable fluorescence, whereas, upon the hydrolytic cleavage of the ester linker, a bright NIR fluorescence appears at λ≈710 nm; this signals release of the drug. Real‐time TDD monitoring is demonstrated for the example of the human pancreatic cancer cell line overexpressing SSTR‐2 and STTR‐5, in comparison with the noncancerous Chinese hamster ovary cell line, which contains a reduced number of these receptors.
- 10 August 2016
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 8 (38) , 6909-6915
A fluorogenic and chromogenic dual sensor for the detection of cyanide and copper(ii) in water samples and living cells
Here we describe a simple fluorescent sensor based on intra molecular charge transfer to detect cyanide in aqueous media selectively with a very good detection limit and cascade recognition of aq. copper(II) ions. Fluorescence quenching was observed due to the Michael addition of cyanide to the dicyanovinyl group of the receptor. A bright yellow solution of R turned colorless during the addition of cyanide ions whereas an intense red solution was obtained during the addition of copper(II) ions. It forms a 1 : 1 adduct with cyanide with a detection limit of 1.76 nM. HRMS of the copper complex formed confirms a 1 : 1 stoichiometric ratio. The sensor has been successfully applied to detect cyanide in water samples. Fluorescence imaging experiments in living cells were also performed, which conclude that the sensor can monitor cyanide in biological samples.
- 10 August 2016
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 8 (38) , 6909-6915
A fluorogenic and chromogenic dual sensor for the detection of cyanide and copper(ii) in water samples and living cells
Here we describe a simple fluorescent sensor based on intra molecular charge transfer to detect cyanide in aqueous media selectively with a very good detection limit and cascade recognition of aq. copper(II) ions. Fluorescence quenching was observed due to the Michael addition of cyanide to the dicyanovinyl group of the receptor. A bright yellow solution of R turned colorless during the addition of cyanide ions whereas an intense red solution was obtained during the addition of copper(II) ions. It forms a 1 : 1 adduct with cyanide with a detection limit of 1.76 nM. HRMS of the copper complex formed confirms a 1 : 1 stoichiometric ratio. The sensor has been successfully applied to detect cyanide in water samples. Fluorescence imaging experiments in living cells were also performed, which conclude that the sensor can monitor cyanide in biological samples.